/
/
/
ヒト肝細胞癌患者由来オルガノイドモデルの開発と最適化による標的同定と創薬
È necessario avere un abbonamento a JoVE per visualizzare questo. Accedi o inizia la tua prova gratuita.
1Affiliated Cancer Hospital and Institute of Guangzhou Medical University, 2Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, Center for Cancer Research and Translational Medicine, School of Basic Medical Sciences,Guangzhou Medical University, 3Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children’s Medical Center,Guangzhou Medical University, 4Department of Hepatobiliary Surgery, Affiliated Cancer Hospital,Guangzhou Medical University
